Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Dec;30(36):6947-54.
doi: 10.1016/j.biomaterials.2009.09.004. Epub 2009 Sep 23.

Iron oxide core oil-in-water emulsions as a multifunctional nanoparticle platform for tumor targeting and imaging

Affiliations

Iron oxide core oil-in-water emulsions as a multifunctional nanoparticle platform for tumor targeting and imaging

Peter A Jarzyna et al. Biomaterials. 2009 Dec.

Abstract

Nanoemulsions are increasingly investigated for the delivery of hydrophobic drugs to improve their bioavailability or make their administration possible. In the current study, oil-in-water emulsions with three different mean diameters (30, 60, and 95 nm) were developed as a new multimodality nanoparticle platform for tumor targeting and imaging. To that aim, hydrophobically coated iron oxide particles were included in the soybean oil core of the nanoemulsions to enable their detection with magnetic resonance imaging (MRI), while the conjugation of a near infrared fluorophore allowed optical imaging. The accumulation of this novel nanocomposite in subcutaneous human tumors in nude mice was demonstrated with MRI and fluorescence imaging in vivo, and with Perl's staining of histological tumor sections ex vivo.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Concept, size determinations and relaxometry
(A) Schematic depiction of the three different sized nanoemulsions used in this study. (B) Dynamic light scattering (DLS) size measurements and photographs of the nanoemulsion preparations. (C) Negative stain transmission electron microscopy (TEM) images of the corresponding formulations (smallest size left). (D) Corresponding values for the longitudinal (r1) and the transverse (r2) relaxivities (n=3, mean ± standard deviation). (E) Zeta potential values.
Figure 2
Figure 2. Pharmacokinetics
(A) Chart showing normalized pharmacokinetic curves of the three nanoemulsions after intravenous injection into nude mice. (B) In vivo NIR fluorescence imaging series showing the accumulation of the 30 nm nanoemulsion in a subcutaneous tumor after intravenous injection. (C) Region of interest (ROI) fluorescence analysis to determine the tumor to skin ratio, i.e. the quotient of the fluorescence photon count from the tumor and the skin determined in a ROI of the same size, for the three different nanoemulsions after intravenous administration.
Figure 3
Figure 3. MR images of nude mice bearing subcutaneous EW7 tumors, injected with the three different nanoemulsions
(A) T2-weighted MR images of the pre-scans (TR 2500 ms, TE 53.3 ms), (B) corresponding T2-weighted MR images 24 h after intravenous injection. The insets show the enlarged MR images of the tumors, respectively. White arrows indicate local hypointense regions within the tumor caused by iron oxide accumulations. (C) 3D images that show the proton density MR image (grey), the whole tumor in 3D (transparent green) and the areas of iron oxide deposition in red. The inset images show an oblique view of the tumor with contrast agent in order to illustrate its 3D structure.
Figure 4
Figure 4. Correlation between MRI and histology
(A) T2-weighted MR image (TR 2500 ms, TE 53.3 ms) of a subcutaneous EW7 tumor in a nude mouse. (B) Corresponding T2-weighted MR image 24 h after injection with the 30 nm nanoemulsion. The hypointense signal within the yellow outline indicates a local area of high iron content. (C) Image of a Perl’s stained histological section of the same tumor showing the iron deposits as blue stained areas. The inset depicts a higher magnification. The area of signal loss seen in the MR image from (B) matches the location of the iron staining (yellow outline) in the histology image from (C).

References

    1. Liu Y, Miyoshi H, Nakamura M. Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles. Int J Cancer. 2007;120:2527–2537. - PubMed
    1. Moghimi SM, Hunter AC, Murray JC. Nanomedicine: current status and future prospects. FASEB J. 2005;19:311–330. - PubMed
    1. Cormode DP, Skajaa T, Fayad ZA, Mulder WJ. Nanotechnology in Medical Imaging. Probe Design and Applications. Arterioscler Thromb Vasc Biol. 2009 advanced online publication. - PMC - PubMed
    1. Bulte JW, Kraitchman DL. Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed. 2004;17:484–499. - PubMed
    1. Medintz IL, Uyeda HT, Goldman ER, Mattoussi H. Quantum dot bioconjugates for imaging, labelling and sensing. Nat Mater. 2005;4:435–446. - PubMed

Publication types

MeSH terms